3 billion anti-bacterial drugs have again been evaluated national medicine, Haussen, Pepper, stone four drugs into the bureau of new collection.
-
Last Update: 2020-07-27
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Pharmaceutical Network July 22nd, July 20, Shi Si Pharmaceutical sipharmaceutical sagencyy issued a notice that the wholly-owned subsidiary has obtained the State Drug Administration on cephalosporini capsules (0.1g) of the drug production registered batch, is the only three enterprises in The country have passed the consistency evaluation, in accordance with the new classification of chemical drugs 4 categories to obtain production approvalFigure 1: Sales of cephalosporini at the terminal of China's public medical institutions (units: 10,000 yuan) data show that in 2019 in China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) terminals, cephalosporine is more than 3 billion heavy varieties, in the internal use of the general name of anti-bacterial drugs TOP20 ranked secondTable 1: The current evaluation of the first spore dini-related product stake in the third round of national collection has been arrow on the string, cephalosporine antibiotics represent the variety of cephalosporini oral permanent release agent form is circled, so far, cephalosporine dispersion tablets have been evaluated by a business, cephalosporine capsule evaluation enterprises up to 3Table 2: 2018 to date in the trial of cephalosporini particle-related products in the current market no granules, 2018 so far there are 5 acceptance number declaration 4 categories of imitation listing, are in the review and approval, the first imitation flower spent who home, we wait and seeSource: Company Announcement, Minnet Database Review Data As of July 21, 2020, if there are any errors, please point out.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.